This is a preview of subscription content, log in via an institution to check access.
Notes
Their work was sponsored by NovoNordisk.
Reference
Wolowacz S, et al. Development and validation of a cost-utility model for Type 1 diabetes mellitus. Diabetic Medicine : 6 Dec 2014. Available from: URL: http://doi.org/10.1111/dme.12663
Rights and permissions
About this article
Cite this article
New economic model for type 1 diabetes proves valid. PharmacoEcon Outcomes News 718, 28 (2014). https://doi.org/10.1007/s40274-014-1793-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1793-z